[老年人急性髓性白血病的最新见解和临床问题]
1Department of Hemato-Oncology, Saitama Medical University International Medical Center.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 1, 2025
概括
基于venetoclax的新疗法显著改善了急性髓性白血病 (AML) 的老年患者的治疗结果. 综合老年病评估和分子分析对于定制治疗策略和改善生存率至关重要.
科学领域:
- 血液学 血液学 血液学
- 老年医学 老年医学
- 在瘤学瘤学.
背景情况:
- 对于老年人来说,传统的急性髓性白血病 (AML) 治疗包括调整强度和扩大标准治疗方案的使用.
- 最近的进展引入了新的药物和组合疗法,改善了结果.
研究的目的:
- 为日本老年人提供AML治疗的概述.
- 讨论当前和新兴的治疗方案,包括分子向药物.
- 突出综合老年医学评估和分子分析在治疗决策中的重要性.
主要方法:
- 对老年人AML当前治疗环境的审查.
- 讨论新药和组合疗法 (例如,venetoclax加azacitidine).
- 强调整合综合老年病评估和分子风险分层.
主要成果:
- 威尼托克拉克斯加上阿扎西提丁和其他新药物显著改善了结果.
- 低强度治疗选择,特别是分子向药物,显示出生存益处.
- 结合老年学评估和分子数据的量身定制的治疗策略至关重要.
结论:
- 为患有AML的老年人选择和结合疗法是复杂的.
- 综合老年医学评估和分子风险标志对于个性化治疗至关重要.
- 未来的药物开发需要明智的方法来优化患者护理.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
237
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
237
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Drug Dosing: Geriatric Patients
227
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
227
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
228
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
228
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197


